Hakutulokset - Tetsuya Mitsudomi

Tarkenna hakua
  1. 1
    Sunvozertinib: shining light on lung cancer’s exon 20 fight

    Sunvozertinib: shining light on lung cancer’s exon 20 fight Tekijä Tetsuya Mitsudomi

    Julkaistu 2025
    Hae kokoteksti
    Carta
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Which biomarker predicts benefit from EGFR-TKI treatment for patients with lung cancer?

    Which biomarker predicts benefit from EGFR-TKI treatment for patients with lung cancer? Tekijä Hidetaka Uramoto, Tetsuya Mitsudomi

    Julkaistu 2007
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Not all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategy

    Not all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategy Tekijä Yoshihisa Kobayashi, Tetsuya Mitsudomi

    Julkaistu 2016
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Utility of the Ba/F3 cell system for exploring on‐target mechanisms of resistance to targeted therapies for lung cancer

    Utility of the Ba/F3 cell system for exploring on‐target mechanisms of resistance to targeted therapies for lung cancer Tekijä T. Koga, Kenichi Suda, Tetsuya Mitsudomi

    Julkaistu 2022
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Heterogeneous Distribution of <i>EGFR</i> Mutations Is Extremely Rare in Lung Adenocarcinoma

    Heterogeneous Distribution of <i>EGFR</i> Mutations Is Extremely Rare in Lung Adenocarcinoma Tekijä Yasushi Yatabe, Keitaro Matsuo, Tetsuya Mitsudomi

    Julkaistu 2011
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    A Screening Method for the ALK Fusion Gene in NSCLC

    A Screening Method for the ALK Fusion Gene in NSCLC Tekijä Yoshiko Murakami, Tetsuya Mitsudomi, Yasushi Yatabe

    Julkaistu 2012
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Ground-glass nodules of the lung in never-smokers and smokers: clinical and genetic insights

    Ground-glass nodules of the lung in never-smokers and smokers: clinical and genetic insights Tekijä Yoshihisa Kobayashi, Chiara Ambrogio, Tetsuya Mitsudomi

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Brain metastases in oncogene-driven non-small cell lung cancer

    Brain metastases in oncogene-driven non-small cell lung cancer Tekijä Makoto Nishino, Kenzo Soejima, Tetsuya Mitsudomi

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Lung Cancer with MET exon 14 Skipping Mutation: Genetic Feature, Current Treatments, and Future Challenges

    Lung Cancer with MET exon 14 Skipping Mutation: Genetic Feature, Current Treatments, and Future Challenges Tekijä Toshio Fujino, Kenichi Suda, Tetsuya Mitsudomi

    Julkaistu 2021
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    The next-generation KRAS inhibitors…What comes after sotorasib and adagrasib?

    The next-generation KRAS inhibitors…What comes after sotorasib and adagrasib? Tekijä Yuko Oya, Kazuyoshi Imaizumi, Tetsuya Mitsudomi

    Julkaistu 2024
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    EGFR T790M Mutation: A Double Role in Lung Cancer Cell Survival?

    EGFR T790M Mutation: A Double Role in Lung Cancer Cell Survival? Tekijä Kenichi Suda, Ryoichi Onozato, Yasushi Yatabe, Tetsuya Mitsudomi

    Julkaistu 2009
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Significance of the Number of Positive Lymph Nodes in Resected Non-small Cell Lung Cancer

    Significance of the Number of Positive Lymph Nodes in Resected Non-small Cell Lung Cancer Tekijä Takayuki Fukui, Shoichi Mori, Kohei Yokoi, Tetsuya Mitsudomi

    Julkaistu 2006
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    Genetic features of pulmonary adenocarcinoma presenting with ground-glass nodules: the differences between nodules with and without growth

    Genetic features of pulmonary adenocarcinoma presenting with ground-glass nodules: the differences between nodules with and without growth Tekijä Yoshihisa Kobayashi, Tetsuya Mitsudomi, Yukinori Sakao, Yasushi Yatabe

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    PTEN and PIK3CA Expression Is Associated with Prolonged Survival after Gefitinib Treatment in EGFR-Mutated Lung Cancer Patients

    PTEN and PIK3CA Expression Is Associated with Prolonged Survival after Gefitinib Treatment in EGFR-Mutated Lung Cancer Patients Tekijä Hideki Endoh, Yasushi Yatabe, Takayuki Kosaka, Hiroyuki Kuwano, Tetsuya Mitsudomi

    Julkaistu 2006
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Predictors of Survival in Patients With Bone Metastasis of Lung Cancer

    Predictors of Survival in Patients With Bone Metastasis of Lung Cancer Tekijä Hideshi Sugiura, Kenji Yamada, Takahiko Sugiura, Toyoaki Hida, Tetsuya Mitsudomi

    Julkaistu 2008
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    Prognostic Implication of EGFR, KRAS, and TP53 Gene Mutations in a Large Cohort of Japanese Patients with Surgically Treated Lung Adenocarcinoma

    Prognostic Implication of EGFR, KRAS, and TP53 Gene Mutations in a Large Cohort of Japanese Patients with Surgically Treated Lung Adenocarcinoma Tekijä Takayuki Kosaka, Yasushi Yatabe, Ryoichi Onozato, Hiroyuki Kuwano, Tetsuya Mitsudomi

    Julkaistu 2009
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Treatment strategies and outcomes for patients with EGFR-mutant non-small cell lung cancer resistant to EGFR tyrosine kinase inhibitors: Focus on novel therapies

    Treatment strategies and outcomes for patients with EGFR-mutant non-small cell lung cancer resistant to EGFR tyrosine kinase inhibitors: Focus on novel therapies Tekijä Melissa L. Johnson, Marina Chiara Garassino, Tony Mok, Tetsuya Mitsudomi

    Julkaistu 2022
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    The insulin‐like growth factor 1 receptor causes acquired resistance to erlotinib in lung cancer cells with the wild‐type epidermal growth factor receptor

    The insulin‐like growth factor 1 receptor causes acquired resistance to erlotinib in lung cancer cells with the wild‐type epidermal growth factor receptor Tekijä Kenichi Suda, Hiroshi Mizuuchi, Katsuaki Sato, Toshiki Takemoto, Takuya Iwasaki, Tetsuya Mitsudomi

    Julkaistu 2014
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Effect of selective lymph node dissection based on patterns of lobe-specific lymph node metastases on patient outcome in patients with resectable non–small cell lung cancer: A large-scale retrospective cohort study applying a propensity score

    Effect of selective lymph node dissection based on patterns of lobe-specific lymph node metastases on patient outcome in patients with resectable non–small cell lung cancer: A larg... Tekijä Futoshi Ishiguro, Keitaro Matsuo, Takayuki Fukui, Shoichi Mori, Shunzo Hatooka, Tetsuya Mitsudomi

    Julkaistu 2009
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Relationship between early recurrence and micrometastases in the lymph nodes of patients with stage I non-small-cell lung cancer

    Relationship between early recurrence and micrometastases in the lymph nodes of patients with stage I non-small-cell lung cancer Tekijä Riichiroh Maruyama, Kenji Sugio, Tetsuya Mitsudomi, Genkichi Saitoh, Teruyoshi Ishida, Keizō Sugimachi

    Julkaistu 1997
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: